- Home
- FGEN vs MNDO Comparison
FGEN vs MNDO Comparison
Compare FGEN & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- MNDO
- Stock Information
- Founded
- FGEN 1993
- MNDO 1995
- Country
- FGEN United States
- MNDO Israel
- Employees
- FGEN N/A
- MNDO N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- FGEN Health Care
- MNDO Technology
- Exchange
- FGEN Nasdaq
- MNDO Nasdaq
- Market Cap
- FGEN 34.0M
- MNDO 39.8M
- IPO Year
- FGEN 2014
- MNDO 2000
- Fundamental
- Price
- FGEN $0.36
- MNDO $1.95
- Analyst Decision
- FGEN
- MNDO
- Analyst Count
- FGEN 0
- MNDO 0
- Target Price
- FGEN N/A
- MNDO N/A
- AVG Volume (30 Days)
- FGEN 1.5M
- MNDO 22.7K
- Earning Date
- FGEN 11-12-2024
- MNDO 11-05-2024
- Dividend Yield
- FGEN N/A
- MNDO 12.50%
- EPS Growth
- FGEN N/A
- MNDO N/A
- EPS
- FGEN N/A
- MNDO 0.23
- Revenue
- FGEN $180,015,000.00
- MNDO $21,856,000.00
- Revenue This Year
- FGEN $20.42
- MNDO N/A
- Revenue Next Year
- FGEN N/A
- MNDO N/A
- P/E Ratio
- FGEN N/A
- MNDO $8.61
- Revenue Growth
- FGEN 16.15
- MNDO 2.27
- 52 Week Low
- FGEN $0.18
- MNDO $1.70
- 52 Week High
- FGEN $2.93
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- FGEN 50.21
- MNDO 48.83
- Support Level
- FGEN $0.18
- MNDO $1.95
- Resistance Level
- FGEN $0.43
- MNDO $2.00
- Average True Range (ATR)
- FGEN 0.04
- MNDO 0.03
- MACD
- FGEN 0.01
- MNDO -0.00
- Stochastic Oscillator
- FGEN 66.94
- MNDO 60.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.